Ledger.Open graph →
SEC Form D · filed September 22, 2015

Adjuvance Technologies Inc

Offering
$7.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

John Gallo · New York, NYDirectorGregory Poland · Rochester, MNDirectorTyler Martin · Roca, NEDirectorJeffrey Gardner · New York, NYExec · DirectorChristopher Frigon · New York, NYExec · DirectorMary Gin · Pelham, NYDirectorPhil Livingston · New York, NYDirectorRobert W. Karr · St. Louis, MOExec · DirectorGregg A. Jacobson · Houston, TXExec · DirectorGeorge H. Capps, Ii · St. Louis, MODirectorCharles A. Bolten · St. Louis, MODirectorGovind Ragupathi · New York, NYDirectorMichael W. Yeadon · St. Louis, MOExec · DirectorDavid W. Griggs · St. Louis, MODirectorThomas P. Cirrito · St. Louis, MODirectorRajesh J. Devraj · St. Louis, MOExec · DirectorAlbert Hummel · Aliso Viejo, CADirectorTodd Gillespie · Aliso Viejo, CADirectorTony Mingo · Aliso Viejo, CADirectorGovind Ragupathi · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗